1 doctor weighed in:
Is a 24 month trial of tasigna (nilotinib) the best way to go about treating a cml diagnosis?
1 doctor weighed in

Dr. Raymundo Romero
Internal Medicine - Oncology
In brief: YES
Tasigna (nilotinib) - was initially used as sencond line treatment for CML for patients resistant or intolerant to imatinib.
Now it is indicated for first line treatment in CML in chronic phase. Its not a trial but treatment for cml. And yes you are right, we only have 24 month data to date as first line treatment.

In brief: YES
Tasigna (nilotinib) - was initially used as sencond line treatment for CML for patients resistant or intolerant to imatinib.
Now it is indicated for first line treatment in CML in chronic phase. Its not a trial but treatment for cml. And yes you are right, we only have 24 month data to date as first line treatment.
Dr. Raymundo Romero
Dr. Raymundo Romero
Thank
Get help from a real doctor now
Dr. Arnon Rubin
Board Certified, Internal Medicine
20 years in practice
162K people helped
Continue
108,000 doctors available
Read more answers from doctors